Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4939)
All Articles published online
|
Jun 21, 2006 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hänsler J, Wissniowski TT, Schuppan D, Witte A, Bernatik T, Hahn EG, Strobel D. Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol 2006; 12(23): 3716-3721 [PMID: 16773688 DOI: 10.3748/wjg.v12.i23.3716] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3716.htm |
| Number | Citing Articles |
| 1 |
Ioana Iancu, Adrian Bartoș, Cristian Cioltean, Caius Breazu, Cornel Iancu, Dana Bartoș. Role of radio‑ablative technique for optimizing the survival of patients with locally advanced pancreatic adenocarcinoma (Review). Experimental and Therapeutic Medicine 2021; 22(2) doi: 10.3892/etm.2021.10285
|
| 2 |
Elena Di Girolamo, Andrea Belli, Alessandro Ottaiano, Vincenza Granata, Valentina Borzillo, Luca Tarotto, Fabiana Tatangelo, Raffaele Palaia, Corrado Civiletti, Mauro Piccirillo, Valentina D’Angelo, Francesco Fiore, Pietro Marone, Guglielmo Nasti, Francesco Izzo, Mario de Bellis. Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1077794
|
| 3 |
Katia Lemdani, Nathalie Mignet, Vincent Boudy, Johanne Seguin, Edward Oujagir, Olivia Bawa, Frédérique Peschaud, Jean-François Emile, Claude Capron, Robert Malafosse. Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma. OncoImmunology 2019; 8(3): 1550342 doi: 10.1080/2162402X.2018.1550342
|
| 4 |
Austin G. Duffy, Oxana V. Makarova‐Rusher, Tim F. Greten. The case for immune‐based approaches in biliary tract carcinoma. Hepatology 2016; 64(5): 1785 doi: 10.1002/hep.28635
|
| 5 |
Gagandeep Brar, Andrew Kesselman, Anuj Malhotra, Manish A. Shah. Redefining Intermediate-Stage HCC Treatment in the Era of Immune Therapies. JCO Oncology Practice 2022; 18(1): 35 doi: 10.1200/OP.21.00227
|
| 6 |
Evangelia M Fatourou, John S Koskinas. Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications. Expert Review of Anticancer Therapy 2009; 9(10): 1499 doi: 10.1586/era.09.103
|
| 7 |
Maarten W. Nijkamp, Alie Borren, Klaas M. Govaert, Frederik J.H. Hoogwater, I. Quintus Molenaar, Paul J. van Diest, Onno Kranenburg, Inne H.M. Borel Rinkes. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. Journal of Surgical Oncology 2010; 101(7): 551 doi: 10.1002/jso.21570
|
| 8 |
Isabella Reccia, Mikael H. Sodergren, Kumar Jayant, Elena Kurz, Adriano Carneiro, Duncan Spalding, Madhava Pai, Long Jiao, Nagy Habib. The journey of radiofrequency-assisted liver resection. Surgical Oncology 2018; 27(2): A16 doi: 10.1016/j.suronc.2018.01.004
|
| 9 |
Jeffrey Rebhun, Claire M Shin, Uzma D Siddiqui, Edward Villa. Endoscopic biliary treatment of unresectable cholangiocarcinoma: A meta-analysis of survival outcomes and systematic review. World Journal of Gastrointestinal Endoscopy 2023; 15(3): 177-190 doi: 10.4253/wjge.v15.i3.177
|
| 10 |
Huojun Zhang, Xiaofei Zhu, Zhaochong Zeng, Xianshu Gao. Integrative Pancreatic Intervention Therapy. 2021; : 523 doi: 10.1016/B978-0-12-819402-7.00023-1
|
| 11 |
David Albers, Arthur Schmidt, Moritz Schiemer, Karel Caca, Andreas Wannhoff, Peter Sauer, Marcel Wiesweg, Brigitte Schumacher, Alexander Dechene. Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter trial. Gastrointestinal Endoscopy 2022; 96(6): 970 doi: 10.1016/j.gie.2022.05.022
|
| 12 |
Daniele Balducci, Michele Montori, Francesco Martini, Marco Valvano, Federico De Blasio, Maria Eva Argenziano, Giuseppe Tarantino, Antonio Benedetti, Emanuele Bendia, Marco Marzioni, Luca Maroni. The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cancers 2024; 16(7): 1372 doi: 10.3390/cancers16071372
|
| 13 |
Hans-Udo Kasper, Christopher Bangard, Axel Gossmann, Hans Peter Dienes, Dirk Ludger Stippel. Pathomorphological changes after radiofrequency ablation in the liver. Pathology International 2010; 60(3): 149 doi: 10.1111/j.1440-1827.2009.02498.x
|
| 14 |
Tim F. Greten, Austin G. Duffy, Firouzeh Korangy. Hepatocellular Carcinoma from an Immunologic Perspective. Clinical Cancer Research 2013; 19(24): 6678 doi: 10.1158/1078-0432.CCR-13-1721
|
| 15 |
Ming-an Yu, Ping Liang. Microwave Ablation Treatment of Solid Tumors. 2015; : 151 doi: 10.1007/978-94-017-9315-5_14
|
| 16 |
Sophia Heinrich, Darko Castven, Peter R. Galle, Jens U. Marquardt. Translational Considerations to Improve Response and Overcome Therapy Resistance in Immunotherapy for Hepatocellular Carcinoma. Cancers 2020; 12(9): 2495 doi: 10.3390/cancers12092495
|
| 17 |
Bertrand Janne d'Othée, Constantinos T. Sofocleous, Nader Hanna, Robert J. Lewandowski, Michael C. Soulen, Jean-Nicolas Vauthey, Steven J. Cohen, Alan P. Venook, Matthew S. Johnson, Andrew S. Kennedy, Ravi Murthy, Jean-Francois Geschwind, Stephen T. Kee. Development of a Research Agenda for the Management of Metastatic Colorectal Cancer: Proceedings from a Multidisciplinary Research Consensus Panel. Journal of Vascular and Interventional Radiology 2012; 23(2): 153 doi: 10.1016/j.jvir.2011.12.003
|
| 18 |
Loukas Thanos, Nikolaos Ptohis, Anastasia Pomoni, Evangelia Sotiropoulou, Mary Pomoni, Dimitrios Kelekis. A Unique Case of Hepatocellular Carcinoma Treated with Radiofrequency Ablation with More than 12 Years Overall Survival: A Case Report. Case Reports in Medicine 2010; 2010: 1 doi: 10.1155/2010/151846
|
| 19 |
Federico Collettini, Carolin Reimann, Julia Brangsch, Julius Chapiro, Lynn Jeanette Savic, David C. Onthank, Simon P. Robinson, Uwe Karst, Rebecca Buchholz, Sarah Keller, Bernd Hamm, S. Nahum Goldberg, Marcus R. Makowski. Elastin-specific MRI of extracellular matrix-remodelling following hepatic radiofrequency-ablation in a VX2 liver tumor model. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86417-6
|
| 20 |
Matthew A. Chiarello, Ryan M. Hickey. Interventional Radiology in the Era of Immuno-Oncology. Advances in Clinical Radiology 2019; 1: 243 doi: 10.1016/j.yacr.2019.04.005
|
| 21 |
Nicola Frenkel, Susanna Poghosyan, Jan Willem van Wijnbergen, Inne Borel Rinkes, Onno Kranenburg, Jeroen Hagendoorn. Differential cytokine and chemokine expression after ablation vs. resection in colorectal cancer liver metastasis. Surgery Open Science 2024; 18: 29 doi: 10.1016/j.sopen.2024.01.005
|
| 22 |
Roberto Girelli, Frigerio Isabella, Alessandro Giardino, Paolo Regi, Filippo Scopelliti, Giovanni Butturini. Diagnosis and Endoscopic Management of Digestive Diseases. 2017; : 43 doi: 10.1007/978-3-319-42358-6_3
|
| 23 |
Dao-Jian Gao, Jian-Feng Yang, Shu-Ren Ma, Jun Wu, Tian-Tian Wang, Hang-Bin Jin, Ming-Xing Xia, Ying-Chun Zhang, Hong-Zhang Shen, Xin Ye, Xiao-Feng Zhang, Bing Hu. Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial. Gastrointestinal Endoscopy 2021; 94(1): 91 doi: 10.1016/j.gie.2020.12.016
|
| 24 |
Xiufeng Liu, Shukui Qin. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges. The Oncologist 2019; 24(S1): S3 doi: 10.1634/theoncologist.2019-IO-S1-s01
|
| 25 |
Yang Zhao, Tongwang Yang, Yabo Ouyang, Wei Rao, Kai Liu, Jiasheng Zheng, Fudong Lv, Ying Shi, Feng Wang, Dongjie Liu, Luxin Qiao, Zhenying Xia, Yushi Zhang, Dexi Chen, Wenjing Wang. Radiofrequency ablation plays double role in immunosuppression and activation of PBMCs in recurrent hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1339213
|
| 26 |
Thomas Josef Vogl, Thaddäus T. Wissniowski, Nagy N. N. Naguib, Renate M. Hammerstingl, Martin G. Mack, Sabine Münch, Matthias Ocker, Deike Strobel, Eckhart G. Hahn, Johannes Hänsler. Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases. Cancer Immunology, Immunotherapy 2009; 58(10): 1557 doi: 10.1007/s00262-009-0663-1
|
| 27 |
Xiao Zheng, Zhi Yuan Bo, Wei Wan, Ye Chen Wu, Tian Tian Wang, Jun Wu, Dao Jian Gao, Bing Hu. Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: A systematic review and meta‐analysis. Journal of Digestive Diseases 2016; 17(11): 716 doi: 10.1111/1751-2980.12429
|
| 28 |
Shunli Shen, Hong Peng, Ye Wang, Ming Xu, Manxia Lin, Xiaoyan Xie, Baogang Peng, Ming Kuang. Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4011-8
|
| 29 |
Samantha M. Ruff, Timothy M. Pawlik. The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence. Hepatoma Research 2024; doi: 10.20517/2394-5079.2024.59
|
| 30 |
Sebastian P. Haen, Philippe L. Pereira, Helmut R. Salih, Hans-Georg Rammensee, Cécile Gouttefangeas. More Than Just Tumor Destruction: Immunomodulation by Thermal Ablation of Cancer. Clinical and Developmental Immunology 2011; 2011: 1 doi: 10.1155/2011/160250
|
| 31 |
Umar Hayat, Muhammad Z. Ashfaq, Muhammad Haseeb, Muhammad L. Farhan, Muhammad Umar Kamal, Khandokar A. Talib, Hafiz M.A. Khan, Ali A. Siddiqui. Adjuvant Radiofrequency Ablation Along With Stenting Versus Stenting Alone for Biliary Tree Drainage in Patients With Malignant Biliary Strictures. Journal of Clinical Gastroenterology 2024; 58(3): 297 doi: 10.1097/MCG.0000000000001851
|
| 32 |
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma, Devendra K. Agrawal. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Molecular and Cellular Biochemistry 2018; 437(1-2): 13 doi: 10.1007/s11010-017-3092-z
|
| 33 |
Zahid Ijaz Tarar, Umer Farooq, Mustafa Gandhi, Ghulam Ghous, Saad Saleem, Faisal Kamal, Zaid Imam, Laith Jamil. Effect of radiofrequency ablation in addition to biliary stent on overall survival and stent patency in malignant biliary obstruction: an updated systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2023; 35(6): 646 doi: 10.1097/MEG.0000000000002568
|
| 34 |
Ligia Craciun, Roland de Wind, Pieter Demetter, Valerio Lucidi, Ali Bohlok, Sébastien Michiels, Fikri Bouazza, Michael Vouche, Ilario Tancredi, Gontran Verset, Soizic Garaud, Céline Naveaux, Maria Gomez Galdon, Karen Willard Gallo, Alain Hendlisz, Ivan Duran Derijckere, Patrick Flamen, Denis Larsimont, Vincent Donckier. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6613-1
|
| 35 |
Hayat Khizar, Yufei Hu, Yanhua Wu, Kamran Ali, Junaid Iqbal, Muhammad Zulqarnain, Jianfeng Yang. Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures. Journal of Clinical Gastroenterology 2023; 57(4): 335 doi: 10.1097/MCG.0000000000001810
|
| 36 |
Yiannis Kallis, Natalie Phillips, Alan Steel, Harry Kaltsidis, Panagiotis Vlavianos, Nagy Habib, David Westaby. Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit. Digestive Diseases and Sciences 2015; 60(11): 3449 doi: 10.1007/s10620-015-3731-8
|
| 37 |
Feng Wu. Therapeutic Ultrasound. Advances in Experimental Medicine and Biology 2016; 880: 131 doi: 10.1007/978-3-319-22536-4_8
|
| 38 |
Stacy K. Y. Fan, Brian Li, Qingyang Chen, Mehran Midia. Impact of Interventional Oncology Therapies on Tumor Microenvironment and Strategies to Enhance Their Efficacy. American Journal of Roentgenology 2018; 210(3): 648 doi: 10.2214/AJR.16.17677
|
| 39 |
Thomas T DeLeon, Yumei Zhou, Bolni M Nagalo, Raquel T Yokoda, Daniel H Ahn, Ramesh K Ramanathan, Marcela A Salomao, Bashar A Aqel, Amit Mahipal, Tanios S Bekaii-Saab, Mitesh J Borad. Novel Immunotherapy Strategies for Hepatobiliary Cancers. Immunotherapy 2018; 10(12): 1077 doi: 10.2217/imt-2018-0024
|
| 40 |
Byung Hyo Cha, Myoung-Jin Jang, Sang Hyub Lee. Survival Benefit of Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction: A Systematic Review with MetaAnalysis. Clinical Endoscopy 2021; 54(1): 100 doi: 10.5946/ce.2020.254
|
| 41 |
Xing-Chen Zhang, Yu-Wen Zhou, Gui-Xia Wei, Yi-Qiao Luo, Meng Qiu. Locoregional therapies combined with immune checkpoint inhibitors for liver metastases. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03484-1
|
| 42 |
Ping-Hung Ho, Wei Teng, Chen-Chun Lin, Wen-Juei Jeng, Wei-Ting Chen, Chun-Yen Lin, Shi-Ming Lin, I-Shyan Sheen. Prolonged post-ablation fever may predict one-year tumor recurrence in hepatocellular carcinoma after radiofrequency ablation. International Journal of Hyperthermia 2020; 37(1): 1008 doi: 10.1080/02656736.2020.1806363
|
| 43 |
Wen Xu Lin, Theodora Fifis, Caterina Malcontenti-Wilson, Mehrdad Nikfarjam, Vijayaragavan Muralidharan, Linh Nguyen, Christopher Christophi. Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases. Journal of Translational Medicine 2011; 9(1) doi: 10.1186/1479-5876-9-83
|
| 44 |
T Schneider, A Sevko, C P Heussel, L Umansky, P Beckhove, H Dienemann, S Safi, J Utikal, H Hoffmann, V Umansky. Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. Clinical and Experimental Immunology 2015; 180(3): 467 doi: 10.1111/cei.12596
|
| 45 |
Andrew Y. Wang, Patrick S. Yachimski. Endoscopic Management of Pancreatobiliary Neoplasms. Gastroenterology 2018; 154(7): 1947 doi: 10.1053/j.gastro.2017.11.295
|
| 46 |
Natasja De Vries, Marloes Swets, Alexander Vahrmeijer, Marianne Hokland, Peter Kuppen. The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment. International Journal of Molecular Sciences 2016; 17(7): 1030 doi: 10.3390/ijms17071030
|
| 47 |
David M. de Jong, Jeska A. Fritzsche, Amber S. Audhoe, Suzanne S. L. Yi, Marco J. Bruno, Rogier P. Voermans, Lydi M. J. W. van Driel. Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma—A Systematic Review and Meta-Analysis. Cancers 2022; 14(9): 2079 doi: 10.3390/cancers14092079
|
| 48 |
Barbara Behm, Pietro Di Fazio, Patrick Michl, Daniel Neureiter, Ralf Kemmerling, Eckhart Georg Hahn, Deike Strobel, Thomas Gress, Detlef Schuppan, Thaddaeus Till Wissniowski. Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation. Gut 2016; 65(1): 134 doi: 10.1136/gutjnl-2014-308286
|
| 49 |
Raphaël Jost, Nael Al-Shatti, Mario Ghosn, Baptiste Bonnet, Stephane Champiat, Frederic Deschamps, Maximiliano Gelli, Valérie Boige, Francois-Xavier Danlos, Sandrine Susini, Antoine Hollebecque, Samy Ammari, Aurelien Marabelle, Thierry de Baere, Lambros Tselikas. Synergizing liver systemic treatments with interventional oncology: friend or foe?. The British Journal of Radiology 2022; 95(1138) doi: 10.1259/bjr.20220548
|
| 50 |
Sevdenur Cizginer, Servet Tatli, Shelley Hurwitz, Kemal Tuncali, Eric vanSonnenberg, Stuart G. Silverman. Biochemical and Hematologic Changes after Percutaneous Radiofrequency Ablation of Liver Tumors: Experience in 83 Procedures. Journal of Vascular and Interventional Radiology 2011; 22(4): 471 doi: 10.1016/j.jvir.2010.12.033
|
| 51 |
Stefaan Mulier, Yicheng Ni, Jacques Jamart, Luc Michel, Guy Marchal, Theo Ruers. Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?. Annals of Surgical Oncology 2008; 15(1): 144 doi: 10.1245/s10434-007-9478-5
|
| 52 |
Aijaz Ahmed Sofi, Muhammad Ali Khan, Ananya Das, Mankanwal Sachdev, Sadik Khuder, Ali Nawras, Wade Lee. Radiofrequency ablation combined with biliary stent placement versus stent placement alone for malignant biliary strictures: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2018; 87(4): 944 doi: 10.1016/j.gie.2017.10.029
|
| 53 |
Amanda R. Smolock, Sarah B. White. Immune Response to Locoregional Therapy. Digestive Disease Interventions 2022; 6(01): 037 doi: 10.1055/s-0041-1742102
|
| 54 |
Marcin Matuszewski, Jerzy Michajłowski, Igor Michajłowski, Katarzyna Ruckermann-Dizurdzińska, Jacek M. Witkowski, Wojciech Biernat, Kazimierz Krajka. Impact of radiofrequency ablation on PBMC subpopulation in patients with renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 2011; 29(6): 724 doi: 10.1016/j.urolonc.2009.11.021
|
| 55 |
Ryan M. Hickey, Laura M. Kulik, Halla Nimeiri, Aparna Kalyan, Sheetal Kircher, Kush Desai, Ahsun Riaz, Robert J. Lewandowski, Riad Salem. Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures. Journal of Vascular and Interventional Radiology 2017; 28(11): 1487 doi: 10.1016/j.jvir.2017.07.018
|
| 56 |
Ahmad Al Nakshabandi, Jeffrey H Lee. Contemporary advances in the endoscopic management of cholangiocarcinoma: a review of accomplished milestones and prospective opportunities. Expert Review of Gastroenterology & Hepatology 2023; 17(2): 175 doi: 10.1080/17474124.2023.2170875
|
| 57 |
Valentina K. Todorova, V. Suzanne Klimberg, Leah Hennings, Thomas Kieber-Emmons, Anastas Pashov. Immunomodulatory Effects of Radiofrequency Ablation in a Breast Cancer Model. Immunological Investigations 2010; 39(1): 74 doi: 10.3109/08820130903428291
|
| 58 |
|
| 59 |
Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, Kaoru Tsuchiya, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Yasunori Minami, Hiroshi Ida, Naoshi Nishida, Chikara Ogawa, Tetsu Tomonari, Noriaki Nakamura, Hidekatsu Kuroda, Atsushi Takebe, Yoshifumi Takeyama, Masaaki Hidaka, Susumu Eguchi, Stephen L Chan, Masayuki Kurosaki, Namiki Izumi. Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study. Liver Cancer 2023; 12(4): 321 doi: 10.1159/000529574
|
| 60 |
Hoonsub So, Chi Hyuk Oh, Tae Jun Song, Hyun Woo Lee, Jun Seong Hwang, Sung Woo Ko, Dongwook Oh, Do Hyun Park, Sang Soo Lee, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim. Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study. Journal of Clinical Medicine 2021; 10(5): 952 doi: 10.3390/jcm10050952
|
| 61 |
Masatoshi Kudo. Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma. Liver Cancer 2022; 11(5): 399 doi: 10.1159/000526163
|
| 62 |
Maria Corina Plaz Torres, Quirino Lai, Fabio Piscaglia, Eugenio Caturelli, Giuseppe Cabibbo, Elisabetta Biasini, Filippo Pelizzaro, Fabio Marra, Franco Trevisani, Edoardo G. Giannini. Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting. Journal of Clinical Medicine 2021; 10(15): 3201 doi: 10.3390/jcm10153201
|
| 63 |
Johanne Seguin, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, Vincent Boudy, Balthazar Toussaint, Frederique Peschaud, Jean François Emile, Claude Capron, Robert Malafosse. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics 2024; 16(3): 315 doi: 10.3390/pharmaceutics16030315
|
| 64 |
Panayiotis Hadjicostas, Demetris Christou, Anastasios Christodoulou. Radiofrequency Ablation of Pancreatic Ductal Adenocarcinoma: An Evolving Comrade?. Journal of Cancer Therapy 2016; 7(13): 1071 doi: 10.4236/jct.2016.713103
|
| 65 |
Austin G. Duffy, Susanna V. Ulahannan, Oxana Makorova-Rusher, Osama Rahma, Heiner Wedemeyer, Drew Pratt, Jeremy L. Davis, Marybeth S. Hughes, Theo Heller, Mei ElGindi, Ashish Uppala, Firouzeh Korangy, David E. Kleiner, William D. Figg, David Venzon, Seth M. Steinberg, Aradhana M. Venkatesan, Venkatesh Krishnasamy, Nadine Abi-Jaoudeh, Elliot Levy, Brad J. Wood, Tim F. Greten. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. Journal of Hepatology 2017; 66(3): 545 doi: 10.1016/j.jhep.2016.10.029
|
| 66 |
Matthew J. Weiss. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012; : 166 doi: 10.1016/B978-1-4377-1454-8.00010-2
|
| 67 |
Ken Kageyama, Akira Yamamoto, Tomohisa Okuma, Shinichi Hamamoto, Toru Takeshita, Yukimasa Sakai, Norifumi Nishida, Toshiyuki Matsuoka, Yukio Miki. Radiofrequency Ablation of Liver Tumors in Combination with Local OK-432 Injection Prolongs Survival and Suppresses Distant Tumor Growth in the Rabbit Model with Intra- and Extrahepatic VX2 Tumors. CardioVascular and Interventional Radiology 2013; 36(5): 1383 doi: 10.1007/s00270-013-0650-y
|
| 68 |
Anna Maria Fietta, Monica Morosini, Ileana Passadore, Alessandro Cascina, Paola Draghi, Roberto Dore, Sandro Rossi, Ernesto Pozzi, Federica Meloni. Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Human Immunology 2009; 70(7): 477 doi: 10.1016/j.humimm.2009.03.012
|
| 69 |
Brian C. Brauer. Intraductal Radiofrequency Ablation (RFA) for Pancreatic Cancer: Getting in Under the Wire?. Digestive Diseases and Sciences 2015; 60(11): 3160 doi: 10.1007/s10620-015-3811-9
|
| 70 |
Liang Zhang, Lichao Xu, Ying Wang, Xiaofei Liu, Mingming Zhang, Wentao Li. Antitumor Immunity Augmented by Combining Radiofrequency Ablation with Anti–CTLA-4 Therapy in a Subcutaneous Murine Hepatoma Model. Journal of Vascular and Interventional Radiology 2020; 31(7): 1178 doi: 10.1016/j.jvir.2020.01.022
|
| 71 |
Gianpiero Gravante, Giuseppe Sconocchia, Seok Ling Ong, Ashley R. Dennison, David M. Lloyd. Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies. Liver International 2009; 29(1): 18 doi: 10.1111/j.1478-3231.2008.01915.x
|
| 72 |
Pramod Rao, Bernard Escudier, Thierry de Baere. Spontaneous Regression of Multiple Pulmonary Metastases After Radiofrequency Ablation of a Single Metastasis. CardioVascular and Interventional Radiology 2011; 34(2): 424 doi: 10.1007/s00270-010-9896-9
|
| 73 |
Betul Gok Yavuz, Elshad Hasanov, Sunyoung S Lee, Yehia I Mohamed, Michael A Curran, Eugene J Koay, Vittorio Cristini, Ahmed O Kaseb. Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; : 1195 doi: 10.2147/JHC.S322289
|
| 74 |
Melanie Widenmeyer, Yuriy Shebzukhov, Sebastian P. Haen, Diethard Schmidt, Stephan Clasen, Andreas Boss, Dmitri V. Kuprash, Sergei A. Nedospasov, Arnulf Stenzl, Hermann Aebert, Dorothee Wernet, Stefan Stevanović, Philippe L. Pereira, Hans‐Georg Rammensee, Cécile Gouttefangeas. Analysis of tumor antigen‐specific T cells and antibodies in cancer patients treated with radiofrequency ablation. International Journal of Cancer 2011; 128(11): 2653 doi: 10.1002/ijc.25601
|
| 75 |
Chenming Liu, Jiaming Dong, Yuxing Liu, Siyuan Zhang, Ruanchang Chen, Haijun Tang. Is endoscopic radiofrequency ablation plus stent placement superior to stent placement alone for the treatment of malignant biliary obstruction? A systematic review and meta-analysis. Journal of International Medical Research 2023; 51(12) doi: 10.1177/03000605231220825
|
| 76 |
Ji-Zhu Xia, Fang-Lin Xie, Li-Feng Ran, Xun-Peng Xie, Yan-Min Fan, Feng Wu. High-Intensity Focused Ultrasound Tumor Ablation Activates Autologous Tumor-Specific Cytotoxic T Lymphocytes. Ultrasound in Medicine & Biology 2012; 38(8): 1363 doi: 10.1016/j.ultrasmedbio.2012.03.009
|
| 77 |
Alice Y. Ho, Shervin Tabrizi, Samantha A. Dunn, Heather L. McArthur. Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer. Breast Cancer Research and Treatment 2022; 191(2): 229 doi: 10.1007/s10549-021-06408-z
|
| 78 |
Nicole J. Kim, Jessica H. Yoon, Adam C. Tuomi, John Lee, Daehee Kim. In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1118845
|
| 79 |
Shinichi Hamamoto, Tomohisa Okuma, Akira Yamamoto, Ken Kageyama, Toru Takeshita, Yukimasa Sakai, Norifumi Nishida, Toshiyuki Matsuoka, Yukio Miki. Radiofrequency Ablation and Immunostimulant OK-432: Combination Therapy Enhances Systemic Antitumor Immunity for Treatment of VX2 Lung Tumors in Rabbits. Radiology 2013; 267(2): 405 doi: 10.1148/radiol.13120249
|
| 80 |
Changqing Xie, Austin G. Duffy, Donna Mabry‐Hrones, Bradford Wood, Elliot Levy, Venkatesh Krishnasamy, Javed Khan, Jun S. Wei, David Agdashian, Manoj Tyagi, Vineela Gangalapudi, Suzanne Fioravanti, Melissa Walker, Victoria Anderson, David Venzon, William D. Figg, Milan Sandhu, David E. Kleiner, Maria Pia Morelli, Charalampos S. Floudas, Gagandeep Brar, Seth M. Steinberg, Firouzeh Korangy, Tim F. Greten. Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer. Hepatology 2019; 69(5): 2048 doi: 10.1002/hep.30482
|
| 81 |
Anthony Bejjani, Richard S. Finn. Current State of Immunotherapy for HCC—Supporting Data and Toxicity Management. Current Hepatology Reports 2018; 17(4): 434 doi: 10.1007/s11901-018-0442-6
|
| 82 |
Salvatore Paiella, Roberto Salvia, Marco Ramera, Roberto Girelli, Isabella Frigerio, Alessandro Giardino, Valentina Allegrini, Claudio Bassi. Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/4508376
|
| 83 |
Yong Liu, Cheng-Song Cao, Yang Yu, Ya-Meng Si. Thermal ablation in cancer. Oncology Letters 2016; 12(4): 2293 doi: 10.3892/ol.2016.4997
|
| 84 |
Nona Janikashvili, Kumar Jayant, Nino Kikodze, Ketevan Mazmishvili, Ia Pantsulaia, Bynvant Sandhu, Mauro Podda, Manana Iobadze, Tamta Azrumelashvili, Malkhaz Mizandari, Nagy Habib, Tinatin Chikovani. Immunomodulatory Changes Following Isolated RF Ablation in Colorectal Liver Metastases: A Case Report. Medicines 2019; 6(2): 56 doi: 10.3390/medicines6020056
|
| 85 |
Hai-tao Guan, Jian Wang, Ming Yang, Li Song, Xiao-qiang Tong, Ying-hua Zou. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients. Chinese Medical Journal 2013; 126(19): 3651 doi: 10.3760/cma.j.issn.0366-6999.20111973
|
| 86 |
Johannes Maximilian Ludwig, Michael Cecchini, Hyun S. Kim. Image-Guided Interventions in Oncology. 2020; : 371 doi: 10.1007/978-3-030-48767-6_21
|
| 87 |
G. N. Machak. ULTRASOUND TUMOR ABLATION: IMMUNE EFFECTS AND PERSPECTIVES OF INTEGRATION IN THE MODERN TREATMENT OF ADVANCED CANCER. Malignant tumours 2018; 8(2): 31 doi: 10.18027/2224-5057-2018-8-2-31-42
|
| 88 |
Andrew S. Mikhail, Robert Morhard, Michal Mauda-Havakuk, Michael Kassin, Antonio Arrichiello, Bradford J. Wood. Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer. Advanced Drug Delivery Reviews 2023; 202: 115083 doi: 10.1016/j.addr.2023.115083
|
| 89 |
Jianhua Wu, Zhiyuan Zhou, Yuanwen Huang, Xinyue Deng, Siting Zheng, Shangwen He, Genjie Huang, Binghui Hu, Min Shi, Wangjun Liao, Na Huang. Radiofrequency ablation: mechanisms and clinical applications. MedComm 2024; 5(10) doi: 10.1002/mco2.746
|
| 90 |
Stefan Nierkens, Martijn H. den Brok, Theo J. Ruers, Gosse J. Adema. Tumor Ablation. 2013; : 39 doi: 10.1007/978-94-007-4694-7_3
|
| 91 |
Salvatore Paiella, Roberto Salvia, Roberto Girelli, Isabella Frigerio, Alessandro Giardino, Mirko D’Onofrio, Giulia De Marchi, Claudio Bassi. Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer. Updates in Surgery 2016; 68(3): 307 doi: 10.1007/s13304-016-0385-9
|
| 92 |
Samantha M. Ruff, Timothy M. Pawlik. Emerging data on immune checkpoint inhibitors in the neoadjuvant and adjuvant setting for patients with hepatocellular carcinoma. Hepatoma Research 2024; doi: 10.20517/2394-5079.2023.144
|